Nextremity Solutions, Inc. Announces New Strategic Direction for Company Following Zimmer Biomet Announcement
WARSAW, IND., Oct. 31, 2016 (GLOBE NEWSWIRE) — Nextremity Solutions, Inc., a musculoskeletal product development company located in “The Orthopedic Capital of the World” Warsaw, IN, recently finalized an exclusive global distribution agreement with Zimmer Biomet for its first four commercialized products, which address unmet clinical needs in forefoot elective surgery.
“Bringing this agreement to closure validates the strategy that our Executive Management Team put into motion at the beginning of the year with the support of our Board of Directors. This strategic shift in our business strategy enables us to focus our efforts on product development and micro-commercialization of innovative technologies in musculoskeletal healthcare,” stated Rod K. Mayer, President and CEO of Nextremity Solutions, Inc.
i3TM Strategic Solutions is Nextremity Solutions’ new strategy to deliver value for Nextremity shareholders and for their industry partners. Through the i3 Strategic Solutions strategy, Nextremity will continue to work with surgeons who are thought leaders in their respective fields to develop and commercialize innovative solutions, at present to the foot and ankle market. In addition to delivering innovative products, Nextremity Solutions, Inc. is committed to establishing effective packaging and delivery systems, creating effective marketing and educational support materials, and providing products with proven sales and clinical efficacy to their industry partners.
“Nextremity Solutions, Inc. has learned a lot over the last 4 years, and we’re taking the best of what we do and doing more of it, more profitably, every day. We’re passionate about serving surgeons, patients, and our industry partners. This has led us to the introduction of i3 Strategic Solutions and we couldn’t be more excited about our future,” stated Ryan D. Schlotterback, Executive Director, Product Development for Nextremity Solutions, Inc.
“It’s what we call our “micro-commercialization” model and is what makes our solutions very different – and more effective,” commented Schlotterback.
Schlotterback further stated, “i3 Strategic Solutions embodies our vision for Nextremity Solutions and is the right model for our future. We are committed to our micro-commercialization strategy and believe that we have the opportunity to deliver solutions to the market in a way that truly leverages our strengths and the strengths of our industry partners, while creating the greatest level of value for everyone involved. We have a very strong internal pipeline and have several external opportunities that we’ve been presented with over the last 6 months that we plan to support with our new model.”
To learn more about i3 Strategic Solutions, visit www.i3strategicsolutions.com.
If you’re a surgeon inventor or have a product idea that you think would be a good fit for Nextremity Solutions, Inc., they can be contacted at 732-383-7901.
About Nextremity Solutions, Inc.
Nextremity Solutions, Inc. is a privately held musculoskeletal product development company offering innovative solutions and approaches to unmet clinical needs in the mind of surgeons and for the benefit of patients worldwide.
For further information, visit www.nextremitysolutions.com or call Dave Temple, Director of Marketing & Corporate Communications at 574-635-3022.
Dave Temple Director of Marketing & Corporate Communications 574-635-3022
